- Efficacy and Safety of Bitopertin in Patients with Schizophrenia and Predominant Negative Symptoms: Subgroup Analysis of Japanese Patients from the Global Randomized Phase 2 Trial
-
Hirayasu Y, Sato SI, Shuto N, Nakano M, Higuchi T
- KMID: 2365014
- Psychiatry Investig.
- 2017 Jan;14(1):63-73.
- doi: 10.4306/pi.2017.14.1.63
OBJECTIVE: The aim of the present study was to perform a subgroup analysis of data from a phase II global, multi-center, randomized, double-blind, placebo-controlled study to evaluate the efficacy and... -
- CITED
-
- Close
- SHARE
-
- Close
